Log In
BCIQ
Print this Print this
 

GC1119

  Manage Alerts
Collapse Summary General Information
Company Green Cross Corp.
DescriptionAnti-galatosidase
Molecular Target Globotriaosylceramide (GL-3)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today